InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,294.69
(
-0.19%
)
US TECH 100
18,323.20
(
0.03%
)
Dow Jones
38,769.46
(
-0.77%
)
Brent Oil
84.29
(
1.74%
)
Bitcoin
68,195.75
(
-1.73%
)
Post# of 251948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 212256

Wednesday, 07/05/2017 6:59:53 PM

Wednesday, July 05, 2017 6:59:53 PM

Post# of 251948

(ADXS)—Neoantigen-vaccine papers in Nature—separate efforts by (private) Neon Therapeutics and (private*) BioNtech

Any advantages/disadvantages you are aware of in comparing the approaches from the three companies to each other or are they all roughly similar in attempting to develop a neoantigen-vaccine?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up